You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Methotrexate and Temozolomide

Showing 1 - 25 of 2,107
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary CNS Lymphoma Trial in Paris (Rituximab, Methotrexate, Temozolomide)

Active, not recruiting
  • Primary Central Nervous System Lymphoma
  • Rituximab, Methotrexate, Temozolomide
  • Paris, France
    Groupe Hospitalier Pitie Salpetriere
Feb 10, 2022

PCNSL Trial in Shanghai (Zanubrutinib, Rituximab, Methotrexate)

Not yet recruiting
  • PCNSL
  • Shanghai, Shanghai, China
    Ruijin Hospital
Jun 8, 2023

Primary CNS Lymphoma, PCNSL, Non Hodgkin Lymphoma Trial in Guandong, Guangzhou (Methotrexate, Ibrutinib, Temozolomide)

Recruiting
  • Primary Central Nervous System Lymphoma
  • +2 more
  • Guandong, Guangdong, China
  • +2 more
Apr 6, 2022

CNS Lymphoma, Secondary CNS Lymphoma Trial run by the National Cancer Institute (NCI) (TEDD-R, TEDDI-R, Ibrutinib)

Recruiting
  • Central Nervous System Lymphoma
  • Secondary Central Nervous System Lymphoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Primary CNS Lymphoma Trial in Zhengzhou (Rituximab, Lenalidomide, Methotrexate)

Recruiting
  • Primary Central Nervous System Lymphoma
  • Zhengzhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Jan 30, 2021

Primary CNS Lymphoma Trial in Worldwide (Rituximab, Methotrexate, Procarbazine)

Recruiting
  • Primary Central Nervous System Lymphoma
  • Aarhus, Denmark
  • +34 more
Nov 4, 2022

Part A: Relapsed or Refractory Primary CNS Lymphoma (PCNSL), Part B: Newly Diagnosed, Treatment naïve PCNSL Trial in United

Recruiting
  • Part A: Relapsed or Refractory Primary Central Nervous System Lymphoma (PCNSL), Part B: Newly Diagnosed, Treatment naïve PCNSL
  • Duarte, California
  • +29 more
Jun 15, 2022

Primary CNS Lymphoma Trial in San Francisco (Hyperpolarized pyruvate (13C), Magnetic resonance imaging (MRI))

Recruiting
  • Primary CNS Lymphoma
  • Hyperpolarized pyruvate (13C)
  • Magnetic resonance imaging (MRI)
  • San Francisco, California
    University of California, San Francisco
Apr 22, 2022

CNS Lymphoma Trial in Aarhus (Immunochemo)

Completed
  • Central Nervous System Lymphoma
  • Aarhus, Denmark
    Elisa Jacobsen Pulczynski
Aug 3, 2022

Evaluation of High Dose Methotrexate Toxicity

Not yet recruiting
  • Methotrexate Toxicity
  • blood methotrexate level and Cystatin C level
  • (no location specified)
Nov 7, 2023

Brain Cancer, Choroid Plexus Tumors Trial in Worldwide (Carboplatin, Cisplatin, Cyclophosphamide)

Terminated
Has Results
  • Brain Cancer
  • Choroid Plexus Tumors
  • Boston, Massachusetts
  • +4 more
Aug 1, 2019

Patients With Cancer Treated With High-dose Methotrexate

Recruiting
  • Acute Kidney Injury
  • Drug Toxicity
  • Marseille, France
  • +4 more
Jun 9, 2023

Newly-diagnosed PCNSL Treated WithMethotrexate and

Active, not recruiting
  • Primary Central Nervous System Lymphoma
  • Shanghai, China
    Department of Hematology, Huashan Hospital, Fudan University
Oct 30, 2023

MGMT-Unmethylated Glioblastoma Trial (Etoposide Plus Cisplatin)

Not yet recruiting
  • MGMT-Unmethylated Glioblastoma
  • Etoposide Plus Cisplatin
  • (no location specified)
Jan 12, 2023

Rheumatoid Arthritis Trial in Dhaka (Baricitinib 2 MG, Methotrexate 25mg)

Recruiting
  • Rheumatoid Arthritis
  • Baricitinib 2 MG
  • Methotrexate 25mg
  • Dhaka, Bangladesh
    Dr. Md. Abu Shahin
Apr 12, 2023

Diabetic Retinopathy, Vitreomacular Traction Trial in Minya (Methotrexate 25 MG/ML, parsplana vitrectomy)

Recruiting
  • Diabetic Retinopathy
  • Vitreomacular Traction
  • Methotrexate 25 MG/ML
  • parsplana vitrectomy
  • Minya, Minia, Egypt
    ophthalmology department, Minia university hospital
Sep 8, 2023

Drug Interactions Trial in Gyeonggi-do (Methotrexate Sodium, Rifampicin)

Enrolling by invitation
  • Drug Interactions
  • Gyeonggi-do, Korea, Republic of
    Seoul National University Bundang Hospital
Oct 25, 2023

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +15 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Chicago, Illinois
  • +2 more
Jan 12, 2023

Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid System Tumor, Metastatic Malignant Solid Tumor Trial (Biopsy,

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +5 more
  • (no location specified)
Jan 18, 2023

Rheumatoid Arthritis Trial in Saint Petersburg (Levilimab)

Active, not recruiting
  • Rheumatoid Arthritis
  • Saint Petersburg, Russian Federation
    X7 Clinical Research
Mar 23, 2023

Newly Diagnosed Glioblastoma Trial in United States (SurVaxM)

Recruiting
  • Newly Diagnosed Glioblastoma
  • SurVaxM
  • San Francisco, California
  • +9 more
Aug 23, 2022

Astrocytoma, IDH-Mutant, Grade 2, Astrocytoma, IDH-Mutant, Grade 3 Trial in United States (other, radiation, drug)

Active, not recruiting
  • Astrocytoma, IDH-Mutant, Grade 2
  • Astrocytoma, IDH-Mutant, Grade 3
  • Questionnaire Administration
  • +3 more
  • Phoenix, Arizona
  • +24 more
Dec 7, 2022

Refractory Solid Tumors Trial in Houston (Eribulin, Irinotecan, Temozolomide)

Recruiting
  • Refractory Solid Tumors
  • Houston, Texas
    M D Anderson Cancer Center
Aug 22, 2023

Anaplastic Astrocytoma, Glioblastoma, Malignant Glioma Trial in Worldwide (Radiation Therapy, Temozolomide, Veliparib)

Active, not recruiting
  • Anaplastic Astrocytoma
  • +2 more
  • Radiation Therapy
  • +2 more
  • Birmingham, Alabama
  • +162 more
Dec 30, 2022

Recurrent Extensive Stage Small Cell Lung Carcinoma, Refractory Extensive Stage Small Cell Lung Carcinoma Trial in United States

Active, not recruiting
  • Recurrent Extensive Stage Small Cell Lung Carcinoma
  • Refractory Extensive Stage Small Cell Lung Carcinoma
  • Bakersfield, California
  • +5 more
Jan 5, 2023